Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference

Lucid Diagnostics (Nasdaq: LUCD) announced that CEO and chairman Lishan Aklog, M.D., will take part in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on Thursday, April 16, 2026 at 10:15 AM EDT.

Rhea-AI Summary

Lucid Diagnostics (Nasdaq: LUCD) announced that CEO and chairman Lishan Aklog, M.D., will take part in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on Thursday, April 16, 2026 at 10:15 AM EDT.

The event will be webcast live and a replay will be archived on the company's Investor Relations website for 30 days.

Argus Apr 9 session

+2.68% close to close Open Argus

Details

News Market Reaction – LUCD

In the Apr 9 session, LUCD gained 2.68%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement adds another investor-relations touchpoint, with Lucid’s CEO presenting at the Nee...

Analysis

This announcement adds another investor-relations touchpoint, with Lucid’s CEO presenting at the Needham conference on April 16, 2026. It follows Q4/FY25 results, where revenue reached $4.7M and net loss was $58.0M, and recent SEC filings including a $175,000,000 shelf and $25,000,000 ATM program. Investors may watch for any new disclosures or commentary on capital plans, commercialization progress, and how management addresses previously flagged going-concern risks.

Key Figures

Conference time: April 16, 2026, 10:15 AM EDT Webcast replay duration: 30 days Shelf registration size: $175,000,000 +5 more

Conference time

April 16, 2026, 10:15 AM EDT

Needham Virtual Healthcare Conference fireside chat

Webcast replay duration

30 days

Replay of fireside chat archived on website

Shelf registration size

$175,000,000

S-3/A shelf filed March 25, 2026

ATM program size

$25,000,000

At-the-market offering under Sales Agreement with Maxim Group LLC

Prior unsold securities

$50,000,000

Unsold securities from prior registration folded into new shelf

Shares outstanding

176,945,972

As of March 20, 2026 per S-3/A

Q4 2025 EsoGuard revenue

$1.5M

Lucid Diagnostics Q4 2025 results

2025 net loss

$58.0M

Lucid Diagnostics full-year 2025 net loss from 8-K/10-K

Historical Context

5 past events · Latest: Apr 02

5 events

1. Apr 02

   Leadership & portfolio

   24h Move

   -0.9%

   PAVmed appointed new medical devices leader and licensed Duke imaging tech.

2. Mar 30

   Earnings & financing

   24h Move

   +2.7%

   PAVmed reported Q4/FY25 results with financings and business update.

3. Mar 26

   Lucid earnings update

   24h Move

   -3.4%

   Lucid reported Q4/FY25 results, VA contract and EsoGuard performance data.

4. Mar 16

   PAVmed call announcement

   24h Move

   +4.4%

   PAVmed announced timing for Q4/FY25 business update call and webcast.

5. Mar 12

   Lucid call announcement

   24h Move

   -4.1%

   Lucid scheduled Q4/FY25 business update conference call and webcast.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, April 9, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that Lishan Aklog, M.D., Lucid's Chairman and Chief Executive Officer, will participate in a fireside chat at the 25^th Annual Needham Virtual Healthcare Conference on Thursday, April 16, 2026 at 10:15 AM EDT.

The fireside chat will be webcast live and available via the Investor Relations Section of the Lucid Diagnostics website or by clicking here.  A replay of the webcast will be archived on the website for 30 days following the live event.

About Lucid Diagnostics
Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid's EsoGuard^® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its EsoCheck^® Esophageal Cell Collection Device, represent the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients.

For more information, please visit www.luciddx.com and for more information about its parent company PAVmed, please visit www.pavmed.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lucid-diagnostics-to-participate-in-fireside-chat-at-the-25th-annual-needham-virtual-healthcare-conference-302736626.html

SOURCE Lucid Diagnostics

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Lucid Diagnostics (LUCD) present at the Needham Virtual Healthcare Conference?

Lucid Diagnostics will present on April 16, 2026 at 10:15 AM EDT in a fireside chat. According to the company, the session features CEO Lishan Aklog and will be webcast live with a 30-day replay on the investor site.

How can investors watch the LUCD fireside chat on April 16, 2026?

Investors can watch the Lucid Diagnostics webcast via the Investor Relations website or the provided live link. According to the company, the fireside chat will be streamed live and a replay will be archived for 30 days after the event.

Who will represent Lucid Diagnostics (LUCD) at the Needham conference fireside chat?

Lishan Aklog, M.D., CEO and chairman of Lucid Diagnostics, will participate in the fireside chat. According to the company, Dr. Aklog will discuss company developments during the April 16, 2026 webcast session at 10:15 AM EDT.

Will the Lucid Diagnostics (LUCD) webcast be available after the live event on April 16, 2026?

Yes, the webcast replay will be archived for 30 days after the live event. According to the company, investors can access the replay via the Investor Relations section of the Lucid Diagnostics website following the April 16 fireside chat.

What topics will Lucid Diagnostics (LUCD) likely cover during the April 16, 2026 fireside chat?

The announcement states the CEO will participate in a company-focused fireside chat at Needham; topics typically include recent developments and strategy. According to the company, the session aims to update investors and will be available via live webcast and 30-day replay.